Condition
Non-Proliferative Diabetic Retinopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Non-Proliferative Diabetic Retinopathy clinical trials that are recruiting, at sites in 3 countries (most in China (2), United Kingdom (1), United States (1)). By phase: Phase 3 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Non-Proliferative Diabetic Retinopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ANXV (Annexin A5) infusions for non-proliferative diabetic retinopathy and retinal vein occlusion | Phase 2 | London | Recruiting | Dec 2, 2025 |
| OTX-TKI (axitinib intravitreal implant) for non-proliferative diabetic retinopathy | Phase 3 | Hagerstown, Maryland | Recruiting | Nov 19, 2025 |
| Evaluating TNTL for treating non-proliferative diabetic retinopathy | Phase 3 | Xuancheng, Anhui and 29 other locations | Recruiting | Feb 10, 2025 |
| Remote ischemic conditioning to treat early diabetic retinopathy | — | Beijing, Beijing Municipality and 1 other locations | Recruiting | Dec 3, 2024 |
All recruiting trials (4)
-
ANXV (Annexin A5) infusions for non-proliferative diabetic retinopathy and retinal vein occlusion
This will test whether short daily infusions of ANXV can be given safely and help improve vision or reduce the need for rescue medication in adults with recent-onset non-proliferative diabetic retinopathy or retinal vein occlusion.
-
OTX-TKI (axitinib intravitreal implant) for non-proliferative diabetic retinopathy
This trial will test whether a long-acting axitinib hydrogel implant injected into one eye can slow worsening in adults with moderately severe to severe non-proliferative diabetic retinopathy.
-
Evaluating TNTL for treating non-proliferative diabetic retinopathy
This study is testing if a new drug called TNTL can help adults with non-proliferative diabetic retinopathy see better and stay safe compared to a placebo.
-
Remote ischemic conditioning to treat early diabetic retinopathy
This trial will test whether remote ischemic conditioning — brief, repeated arm cuff inflations — helps adults aged 40–80 with mild-to-moderate non-proliferative diabetic retinopathy.
Related topics
Quick answers
How many Non-Proliferative Diabetic Retinopathy clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.